Published in Proc Natl Acad Sci U S A on July 15, 2002
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Quantifying T lymphocyte turnover. J Theor Biol (2013) 1.35
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci (2006) 1.24
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol (2006) 0.99
A mechanistic model for bromodeoxyuridine dilution naturally explains labelling data of self-renewing T cell populations. J R Soc Interface (2012) 0.92
Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants. Retrovirology (2004) 0.92
Animal models on HTLV-1 and related viruses: what did we learn? Front Microbiol (2012) 0.88
Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle. J Virol (2003) 0.85
Vaccination against δ-retroviruses: the bovine leukemia virus paradigm. Viruses (2014) 0.84
Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol (2006) 0.83
Earlier onset of delta-retrovirus-induced leukemia after splenectomy. PLoS One (2009) 0.81
Recent Advances in BLV Research. Viruses (2015) 0.80
Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads. Retrovirology (2009) 0.78
Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence. Viruses (2015) 0.77
Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science (1982) 10.61
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science (1998) 3.39
Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci U S A (1982) 3.19
Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature (1984) 2.78
Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol (2001) 2.54
Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01
Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology (1988) 1.96
Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci U S A (1998) 1.88
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J (1996) 1.69
Quantification of cell turnover kinetics using 5-bromo-2'-deoxyuridine. J Immunol (2000) 1.67
Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66
Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol (1998) 1.66
Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst (2001) 1.64
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia. Nature (1984) 1.58
Measurement of T-cell kinetics: recent methodologic advances. Immunol Today (1999) 1.46
Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol (1998) 1.43
Bovine leukemia virus, an animal model for the study of intrastrain variability. J Virol (1993) 1.38
Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol (1998) 1.38
The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat. Cancer Res (1962) 1.30
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses (1994) 1.19
Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.18
Human leukemia virus associated with adult T-cell leukemia. Gan (1983) 1.17
Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses (2000) 1.16
Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene (1995) 1.16
Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. J Biol Chem (2000) 1.15
Accelerated G(1) phase progression induced by the human T cell leukemia virus type I (HTLV-I) Tax oncoprotein. J Biol Chem (2001) 1.12
Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol (1997) 1.11
Characteristics of lymphocyte responses to phytomitogens: comparison of responses of lymphocytes from normal and lymphocytotic cows. Am J Vet Res (1974) 1.09
Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J Virol (2001) 1.03
Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer. Adv Vet Sci Comp Med (1988) 1.00
Human retroviruses in the second decade: a personal perspective. Nat Med (1995) 0.99
HTLV-1 infections. J Clin Pathol (2000) 0.99
Molecular biology of chronic lymphocytic leukemia. Semin Oncol (1998) 0.98
Bovine leukaemia virus-induced lymphocytosis in sheep is associated with reduction of spontaneous B cell apoptosis. J Gen Virol (1997) 0.97
Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection. Blood (1991) 0.96
Persistent lymphocytosis in cattle: its cause, nature and relation to lymphosarcoma. Ann Rech Vet (1978) 0.94
Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation. Oncogene (1998) 0.93
Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes. Clin Immunol Immunopathol (1994) 0.92
Apoptosis and the pathogenesis of lymphoma. Acta Oncol (2000) 0.91
Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep. J Virol (1998) 0.91
Bovine leukemia virus-induced persistent lymphocytosis in cattle does not correlate with increased ex vivo survival of B lymphocytes. J Virol (1999) 0.88
Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo. J Virol (2000) 0.87
The effects of prolonged administration of 5-bromodeoxyuridine on cells of the immune system. J Immunol (2000) 0.80
FACS analysis of bovine leukemia virus (BLV)-infected cell lines with monoclonal antibodies (mAbs) to B cells and to monocytes/macrophages. Vet Immunol Immunopathol (1991) 0.80
Considerations on B cell homeostasis. Curr Top Microbiol Immunol (2000) 0.79
Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS One (2009) 2.23
The HTLV-1 Tax interactome. Retrovirology (2008) 2.02
Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol (2009) 1.81
Reduction of B cell turnover in chronic lymphocytic leukaemia. Br J Haematol (2008) 1.74
Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J Exp Med (2005) 1.72
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Measurement and modeling of human T cell kinetics. Eur J Immunol (2003) 1.61
B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood (2005) 1.52
DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection. Eur J Immunol (2007) 1.50
Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol Cell Biol (2005) 1.47
Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol (2002) 1.44
Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol Res (2008) 1.40
A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code. Trends Biochem Sci (2008) 1.36
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology (2007) 1.35
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci (2006) 1.24
Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis. Proc Natl Acad Sci U S A (2008) 1.18
Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol (2004) 1.17
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology (2012) 1.16
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14
Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci (2007) 1.13
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med (2013) 1.11
New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol Cell Biol (2006) 1.11
Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma. Proc Natl Acad Sci U S A (2013) 1.08
Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst (2003) 1.08
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner. Mol Cancer Ther (2006) 1.07
Class IIa histone deacetylases: conducting development and differentiation. Int J Dev Biol (2009) 1.07
Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Mol Cell Biol (2003) 1.04
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunol Immunother (2004) 1.04
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis (2004) 1.04
Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol (2002) 1.04
Rapid turnover of T cells in acute infectious mononucleosis. Eur J Immunol (2003) 1.03
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog (2011) 1.02
Evaluation of tests for antibodies against bovine herpesvirus 1 performed in national reference laboratories in Europe. Vet Microbiol (2004) 1.02
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci U S A (2005) 1.02
Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res (2009) 1.01
Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans. Blood (2013) 1.01
The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci (Landmark Ed) (2009) 1.00
In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis (2011) 1.00
MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Biochim Biophys Acta (2005) 1.00
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol (2006) 0.99
T-cell epitope prediction: rescaling can mask biological variation between MHC molecules. PLoS Comput Biol (2009) 0.99
Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res (2005) 0.99
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc Natl Acad Sci U S A (2004) 0.99
The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol (2009) 0.99
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood (2007) 0.98
Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells. J Virol (2006) 0.98
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood (2011) 0.98
Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. J Virol (2002) 0.98
Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog (2013) 0.97
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol (2008) 0.97
Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood (2011) 0.97
Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol (2002) 0.97
HTLV-1: persistence and pathogenesis. Virology (2013) 0.97
Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose. Nat Protoc (2009) 0.95
Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo? PLoS Comput Biol (2011) 0.95
Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. Virology (2009) 0.94
Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. Eur J Cancer (2010) 0.94
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Exp Hematol (2007) 0.94
MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem (2012) 0.93
Microorganisms living on macroalgae: diversity, interactions, and biotechnological applications. Appl Microbiol Biotechnol (2014) 0.93